Congress · Basel, Switzerland
World Immunotherapy Congress
Business, Franchising, Licensing
Key numbers
- Editions on record
- 2first in 2016
About World Immunotherapy Congress
Immunotherapy currently offers the brightest hope for cancer treatment. New developments with checkpoint inhibitors and co-stimulatory targets have enabled some stunning breakthroughs and high optimism for the sector. Recently, there have been some incredibly exciting new therapies in areas such as CAR-T and Oncolytic Viral Immunotherapy. Our vision is to bring together the full community and provide a single meeting point for the whole value chain. It is where science meets business to make immunotherapy the cornerstone of the fight against cancer. After a first successful edition, the World Immunotherapy Congress will once again bring leading clinicians, pharmaceutical companies, biotechs and research institutes together, and will take place alongside the flagship European Antibody Congress, as well as the World Biosimilar Congress and the World HPAPI Congress.
From our listing of this edition. Details may have changed since.
Editions
| Year | Dates | Where | Exhibitors | Visitors |
|---|---|---|---|---|
| 2017 | 31 Oct – 2 Nov 2017 | Kongress Zentrum Basel Basel, Switzerland | — | — |
| 2016 | 14–16 Nov 2016 | Kongress Zentrum Basel Basel, Switzerland | — | — |
Past editions from the bvents archive (2008–2019) and organiser figures where they were published.
Questions
When is World Immunotherapy Congress?
The next dates haven't been confirmed. The last edition we have on record was 31 Oct – 2 Nov 2017.
Where is it held?
The last edition we have was at Kongress Zentrum Basel, Basel, Switzerland.